SOF/VEL + RBV
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SOF/VEL + RBV, covering 2022-07-21 to 2022-07-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis [Phase 4]